Cite

HARVARD Citation

    Azorin, P. et al. (2022). Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types. Clinical and translational medicine. 12 (4), p. n/a. [Online]. 
  
Back to record